kinj28

Problem with modern grains 1) gluten 2) weed killers/ pesticides 3) lack of nutritional value

My father and many other people in my family increased to neutral millets and started giving up wheat as much as they can.

Those problems are worth solving for or roll back to grossini seeds and use his creative technique to not let it withered by wind and let’s you have better nutritional value

Today open AI is serving ads to App free users post their queries. If the ad is relevant and adjacent to the query then it does show the ad in the chat. It isn’t clear how relevant ads are and users behaviour on this yet but worth experimenting to learn.

Pre-AI, we used to spend upwards of $60K a year on Google Ads to keep our inbound pipeline running.

In the post-AI world, that spend dropped to $0. Not because Google Search suddenly stopped working, but because our segment (low-code platforms) was one of those that AI was going to disrupt significantly. We had to rethink and adapt our offering to the AI world before doubling down on marketing.

Now that we’ve repositioned and adapted our product, our marketing team has started experimenting with OpenAI as a channel, but we haven’t switched Google Ads back on.

There’s also something I find interesting about this shift. Google Ads always felt a bit like a mafia tax. When we stopped paying, our organic traffic seemed to take a disproportionate hit too. We could never quite figure out why. Maybe it was coincidence, maybe something else, but it left us questioning how independent organic search traffic really was from paid search.

update -- been over 5 days and google has just kept pushing their time lines. saying it needs cross team evaluation. I had similar experience with AWS and they were swift to give back credits to us. this tells me some serious issues with google and their org structure if this 2500$ is taking them a long long time to decide and involves cross functional teams. or maybe they have many more such incidents and adding up many more $$ or this is the 1st of its kind and are now putting an SOP. any one from google here?

I would like to imagine pacing frontier is in interest of both (anthropic and open AI) as it will enable them to enlarged their depreciation

I would like to imagine accounting inference revenue on trained model and the depreciation cost for training that specific model must already been capitalized + compute to serve would be a net positive margin business. Ongoing training must rather be for future models.

But again once future models arrive they would render older models useless, so the asset must be depreciating really fast.

Would love someone to throw light on revenue and cost recognition at the unit level for this.

My father has gastric melonama and pretty much last few days left — does someone with knowledge know if this vaccine can be of any help? Or any registry available?

I cold emailed a researcher in Japan about gut bacteria e. Americana for cancer treatment and registering my dad for clinical trials as and when they happen. And hell yea - professor replied :)

So yes — just do it!

But isn’t the case that faster you fail you get to the goal post better? Terminally ill trial vs non terminally ill can be differentiated somehow while measuring efficacy and other post trial parameters ?